Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review
Authors
Keywords
-
Journal
CLINICAL & EXPERIMENTAL METASTASIS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-25
DOI
10.1007/s10585-021-10136-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Novel Role for NUAK1 in Promoting Ovarian Cancer Metastasis through Regulation of Fibronectin Production in Spheroids
- (2020) Jamie Lee Fritz et al. Cancers
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
- (2019) Edith Emmings et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- Therapeutic Targeting of Collective Invasion in Ovarian Cancer
- (2019) Laura Moffitt et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
- (2019) Oded Kopper et al. NATURE MEDICINE
- The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
- (2019) Nele Loret et al. Cancers
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma Patients
- (2018) Jing He et al. MEDICAL SCIENCE MONITOR
- Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models
- (2018) Daniel Newsted et al. OncoImmunology
- High grade serous ovarian carcinomas originate in the fallopian tube
- (2017) S. Intidhar Labidi-Galy et al. Nature Communications
- Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review
- (2017) et al. Cancers
- The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications
- (2016) Ivo Meinhold-Heerlein et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Cancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrin
- (2016) Wei-Ching Chen et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer
- (2016) Mingzhu Yin et al. JOURNAL OF CLINICAL INVESTIGATION
- TGFβ signaling regulates epithelial–mesenchymal plasticity in ovarian cancer ascites-derived spheroids
- (2015) Samah Rafehi et al. ENDOCRINE-RELATED CANCER
- Confocal Imaging–Guided Laser Ablation of Basal Cell Carcinomas: An Ex Vivo Study
- (2015) Heidy Sierra et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Spherical Cancer Models in Tumor Biology
- (2015) Louis-Bastien Weiswald et al. NEOPLASIA
- The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle
- (2015) Angela Cho et al. Frontiers in Oncology
- Tumor-Selective Response to Antibody-Mediated Targeting of αvβ3 Integrin in Ovarian Cancer
- (2015) Charles N. Landen et al. NEOPLASIA
- Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability
- (2014) Rohann J.M. Correa et al. CARCINOGENESIS
- Remodelling the extracellular matrix in development and disease
- (2014) Caroline Bonnans et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Ovulation and extra-ovarian origin of ovarian cancer
- (2014) Yang Yang-Hartwich et al. Scientific Reports
- Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
- (2013) Ruth Perets et al. CANCER CELL
- A CD90+ Tumor-Initiating Cell Population with an Aggressive Signature and Metastatic Capacity in Esophageal Cancer
- (2013) K. H. Tang et al. CANCER RESEARCH
- Cell cycle arrest or survival signaling through αv integrins, activation of PKC and ERK1/2 lead to anoikis resistance of ovarian cancer spheroids
- (2013) Ludovic Carduner et al. EXPERIMENTAL CELL RESEARCH
- Cell–cell and cell–matrix dynamics in intraperitoneal cancer metastasis
- (2012) Katharine L. Sodek et al. CANCER AND METASTASIS REVIEWS
- Astrocytic αVβ3 Integrin Inhibits Neurite Outgrowth and Promotes Retraction of Neuronal Processes by Clustering Thy-1
- (2012) Rodrigo Herrera-Molina et al. PLoS One
- Spontaneous spheroid budding from monolayers: a potential contribution to ovarian cancer dissemination
- (2012) J. C. Pease et al. Biology Open
- Role of β5-integrin in epithelial-mesenchymal transition in response to TGF-β
- (2011) Anna Bianchi et al. CELL CYCLE
- A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
- (2011) Katherine M. Bell-McGuinn et al. GYNECOLOGIC ONCOLOGY
- Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti-αV-Integrin Antibody
- (2011) Marta Bellone et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The Matrisome:In SilicoDefinition andIn VivoCharacterization by Proteomics of Normal and Tumor Extracellular Matrices
- (2011) Alexandra Naba et al. MOLECULAR & CELLULAR PROTEOMICS
- Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype
- (2011) J Jiang et al. ONCOGENE
- Overview of the Matrisome--An Inventory of Extracellular Matrix Constituents and Functions
- (2011) R. O. Hynes et al. Cold Spring Harbor Perspectives in Biology
- Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium
- (2011) Marcin P. Iwanicki et al. Cancer Discovery
- Integrin Inhibitors as a Therapeutic Agent for Ovarian Cancer
- (2011) Kenjiro Sawada et al. Journal of Oncology
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Integrin targeted drug and gene delivery
- (2010) Zhe Wang et al. Expert Opinion on Drug Delivery
- Intraperitoneal therapy for peritoneal cancer
- (2010) Ze Lu et al. Future Oncology
- Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin
- (2010) Sabrina Kellouche et al. TUMOR BIOLOGY
- β 3 -Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer
- (2009) Swayamjot Kaur et al. AMERICAN JOURNAL OF PATHOLOGY
- Ovarian Cancer Cell Detachment and Multicellular Aggregate Formation Are Regulated by Membrane Type 1 Matrix Metalloproteinase: A Potential Role in I.p. Metastatic Dissemination
- (2009) N. M. Moss et al. CANCER RESEARCH
- Vascular Cell Adhesion Molecule-1 Is a Regulator of Ovarian Cancer Peritoneal Metastasis
- (2009) Jill K. Slack-Davis et al. CANCER RESEARCH
- The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer
- (2009) Constanze Banz et al. FERTILITY AND STERILITY
- Neuronal Thy-1 induces astrocyte adhesion by engaging syndecan-4 in a cooperative interaction with v 3 integrin that activates PKC and RhoA
- (2009) A. M. Avalos et al. JOURNAL OF CELL SCIENCE
- Ovarian Cancer Pathogenesis: A Model in Evolution
- (2009) Alison M. Karst et al. Journal of Oncology
- Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
- (2008) Zhen Fan Yang et al. CANCER CELL
- Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via 5-Integrin, which Is a Therapeutic Target
- (2008) K. Sawada et al. CANCER RESEARCH
- Pharmacology of the Novel Antiangiogenic Peptide ATN-161 (Ac-PHSCN-NH2): Observation of a U-Shaped Dose-Response Curve in Several Preclinical Models of Angiogenesis and Tumor Growth
- (2008) F. Donate et al. CLINICAL CANCER RESEARCH
- Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype
- (2008) Katharine L. Sodek et al. INTERNATIONAL JOURNAL OF CANCER
- The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin
- (2008) Hilary A. Kenny et al. JOURNAL OF CLINICAL INVESTIGATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started